{
    "nct_id": "NCT02466113",
    "official_title": "A Multi-site, Open, Perspective Study of Prognostic Value and Benefit From Chemotherapy of Stage II Colon Cancer Based on a 6 microRNA Stratified Tool",
    "criteria": {
        "raw_text": "Inclusion Criteria:\n\n* The informed consent has been obtained from the patient.\n* With confirmed diagnosis of stage II colon cancer.\n* With moderate/good ECOG health rating (PS): 0-1 score.\n* The patient receive no anti-cancer treatment before primary surgery.\n* The patient receive radical operation for colon cancer with negative margin.\n\nExclusion Criteria:\n\n* With severe comorbidities, such as cardiovascular disease, chronic obstructive pulmonary disease, diabetes mellitus, and chronic renal dysfunction.\n* With bad compliance or contraindication to enrollment.\n* Pregnant woman or lactating woman.\n* With contraindication to receive adjuvant chemotherapy.\n\nsex: ALL\n\nminimumAge: 18 Years\n\nmaximumAge: 65 Years\n\nstdAges: ['ADULT', 'OLDER_ADULT']",
        "inclusion": "* The informed consent has been obtained from the patient.\n* With confirmed diagnosis of stage II colon cancer.\n* With moderate/good ECOG health rating (PS): 0-1 score.\n* The patient receive no anti-cancer treatment before primary surgery.\n* The patient receive radical operation for colon cancer with negative margin.",
        "exclusion": "* With severe comorbidities, such as cardiovascular disease, chronic obstructive pulmonary disease, diabetes mellitus, and chronic renal dysfunction.\n* With bad compliance or contraindication to enrollment.\n* Pregnant woman or lactating woman.\n* With contraindication to receive adjuvant chemotherapy."
    }
}